Amarin Corporation plc (AMRN) — Stock Score Summary

Amarin Corporation plc (AMRN) has a MoatMap StockRank of 67/100 based on Quality (48/100), Value (52/100), and Momentum (51/100) factor scores. The current signal is BUY. Amarin is a broken business model facing severe generic competition for its core product, Vascepa. It fails our Terry Smith screen against turnarounds and structurally challenged businesses.

Amarin Corporation plc is an Irish pharmaceutical company dedicated to the development and commercialization of therapeutics for cardiovascular health, centered on its flagship product, Vascepa. The company's market position is defined by its pioneering work in purified omega-3 prescription drugs, though it currently faces intense generic competition in the United States. Amarin is actively transitioning its growth strategy toward European and international markets where it retains stronger patent protection and regulatory exclusivity.

Key Financial Metrics

Price$14.53
Market Cap$302M
P/E (Forward)14.72
Price/Book0.67
Return on Equity-7.3%
Return on Invested Capital-7.6%
Debt/Equity1.71
Gross Margin52.4%
Operating Margin-17.8%
Revenue Growth7.4%
Free Cash Flow$2M

Amarin Corporation plc operates in the Drug Manufacturers - General industry, part of the Healthcare sector (Ireland).

Frequently Asked Questions

What is Amarin Corporation plc’s (AMRN) StockRank?
MoatMap’s StockRank for Amarin Corporation plc (AMRN) is 67/100, with a Buy signal. It is a composite of Quality (48), Value (52), and Momentum (51) factor ranks across MoatMap’s 19,000+ stock universe.
Does Amarin Corporation plc have an economic moat?
Amarin Corporation plc (AMRN) has a Quality factor score of 48/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Amarin Corporation plc a buy, hold, or sell?
MoatMap’s current signal for Amarin Corporation plc (AMRN) is Buy, based on a StockRank of 67/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Amarin Corporation plc in?
Amarin Corporation plc (AMRN) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry (Ireland).
Browse all ranked stocksAMRN deep dive reportAI ChampionsHow we score stocksSense-check another stock